Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Interference between pressure-wire and deployed coronary stents: Insights from a bench test.

Warisawa T, Nour D, Seligman H, Doi S, Kuwata S, Howard JP, Rajkumar C, Cook CM, Nakayama Y, Kasahara M, Suzuki N, Matsuda H, Mizuno K, Akashi YJ.

Cardiovasc Revasc Med. 2019 Oct 27. pii: S1553-8389(19)30679-7. doi: 10.1016/j.carrev.2019.10.026. [Epub ahead of print]

PMID:
31784356
2.

Determining the Predominant Lesion in Patients With Severe Aortic Stenosis and Coronary Stenoses: A Multicenter Study Using Intracoronary Pressure and Flow.

Ahmad Y, Vendrik J, Eftekhari A, Howard JP, Cook C, Rajkumar C, Malik I, Mikhail G, Ruparelia N, Hadjiloizou N, Nijjer S, Al-Lamee R, Petraco R, Warisawa T, Wijntjens GWM, Koch KT, van de Hoef T, de Waard G, Echavarria-Pinto M, Frame A, Sutaria N, Kanaganayagam G, Ariff B, Anderson J, Chukwuemeka A, Fertleman M, Koul S, Iglesias JF, Francis D, Mayet J, Serruys P, Davies J, Escaned J, van Royen N, Götberg M, Juhl Terkelsen C, Høj Christiansen E, Piek JJ, Baan J Jr, Sen S.

Circ Cardiovasc Interv. 2019 Dec;12(12):e008263. doi: 10.1161/CIRCINTERVENTIONS.119.008263. Epub 2019 Nov 22.

3.

Dobutamine Stress Echocardiography Ischemia as a Predictor of the Placebo-Controlled Efficacy of Percutaneous Coronary Intervention in Stable Coronary Artery Disease: The Stress Echocardiography-Stratified Analysis of ORBITA.

Al-Lamee RK, Shun-Shin MJ, Howard JP, Nowbar AN, Rajkumar C, Thompson D, Sen S, Nijjer S, Petraco R, Davies J, Keeble T, Tang K, Malik I, Bual N, Cook C, Ahmad Y, Seligman H, Sharp ASP, Gerber R, Talwar S, Assomull R, Cole G, Keenan NG, Kanaganayagam G, Sehmi J, Wensel R, Harrell FE Jr, Mayet J, Thom S, Davies JE, Francis DP.

Circulation. 2019 Dec 10;140(24):1971-1980. doi: 10.1161/CIRCULATIONAHA.119.042918. Epub 2019 Nov 11.

4.

Renal denervation: The three stages of academic grief.

Howard JP.

Trends Cardiovasc Med. 2019 Oct 22. pii: S1050-1738(19)30141-0. doi: 10.1016/j.tcm.2019.05.014. [Epub ahead of print] No abstract available.

PMID:
31677905
5.

Artificial Intelligence for Aortic Pressure Waveform Analysis During Coronary Angiography: Machine Learning for Patient Safety.

Howard JP, Cook CM, van de Hoef TP, Meuwissen M, de Waard GA, van Lavieren MA, Echavarria-Pinto M, Danad I, Piek JJ, Götberg M, Al-Lamee RK, Sen S, Nijjer SS, Seligman H, van Royen N, Knaapen P, Escaned J, Francis DP, Petraco R, Davies JE.

JACC Cardiovasc Interv. 2019 Oct 28;12(20):2093-2101. doi: 10.1016/j.jcin.2019.06.036. Epub 2019 Sep 25.

PMID:
31563678
6.

Meta-Analysis of Randomized Controlled Trials of Atrial Fibrillation Ablation With Pulmonary Vein Isolation Versus Without.

Sau A, Howard JP, Al-Aidarous S, Ferreira-Martins J, Al-Khayatt B, Lim PB, Kanagaratnam P, Whinnett ZI, Peters NS, Sikkel MB, Francis DP, Sohaib SMA.

JACC Clin Electrophysiol. 2019 Aug;5(8):968-976. doi: 10.1016/j.jacep.2019.05.012. Epub 2019 Jul 31.

7.

Algorithmic Versus Expert Human Interpretation of Instantaneous Wave-Free Ratio Coronary Pressure-Wire Pull Back Data.

Cook CM, Warisawa T, Howard JP, Keeble TR, Iglesias JF, Schampaert E, Bhindi R, Ambrosia A, Matsuo H, Nishina H, Kikuta Y, Shiono Y, Nakayama M, Doi S, Takai M, Goto S, Yakuta Y, Karube K, Akashi YJ, Clesham GJ, Kelly PA, Davies JR, Karamasis GV, Kawase Y, Robinson NM, Sharp ASP, Escaned J, Davies JE.

JACC Cardiovasc Interv. 2019 Jul 22;12(14):1315-1324. doi: 10.1016/j.jcin.2019.05.025.

8.

Quantification of Electromechanical Coupling to Prevent Inappropriate Implantable Cardioverter-Defibrillator Shocks.

Keene D, Shun-Shin MJ, Arnold AD, Howard JP, Lefroy D, Davies DW, Lim PB, Ng FS, Koa-Wing M, Qureshi NA, Linton NWF, Shah JS, Peters NS, Kanagaratnam P, Francis DP, Whinnett ZI.

JACC Clin Electrophysiol. 2019 Jun;5(6):705-715. doi: 10.1016/j.jacep.2019.01.025. Epub 2019 Mar 27.

9.

Mortality From Ischemic Heart Disease.

Nowbar AN, Gitto M, Howard JP, Francis DP, Al-Lamee R.

Circ Cardiovasc Qual Outcomes. 2019 Jun;12(6):e005375. doi: 10.1161/CIRCOUTCOMES.118.005375. Epub 2019 Jun 4.

10.

Cardiac Rhythm Device Identification Using Neural Networks.

Howard JP, Fisher L, Shun-Shin MJ, Keene D, Arnold AD, Ahmad Y, Cook CM, Moon JC, Manisty CH, Whinnett ZI, Cole GD, Rueckert D, Francis DP.

JACC Clin Electrophysiol. 2019 May;5(5):576-586. doi: 10.1016/j.jacep.2019.02.003. Epub 2019 Mar 27.

11.

Physiological Pattern of Disease Assessed by Pressure-Wire Pullback Has an Influence on Fractional Flow Reserve/Instantaneous Wave-Free Ratio Discordance.

Warisawa T, Cook CM, Howard JP, Ahmad Y, Doi S, Nakayama M, Goto S, Yakuta Y, Karube K, Shun-Shin MJ, Petraco R, Sen S, Nijjer S, Al Lamee R, Ishibashi Y, Matsuda H, Escaned J, di Mario C, Francis DP, Akashi YJ, Davies JE.

Circ Cardiovasc Interv. 2019 May;12(5):e007494. doi: 10.1161/CIRCINTERVENTIONS.118.007494.

12.

Association Between Physiological Stenosis Severity and Angina-Limited Exercise Time in Patients With Stable Coronary Artery Disease.

Cook CM, Ahmad Y, Howard JP, Shun-Shin MJ, Sethi A, Clesham GJ, Tang KH, Nijjer SS, Kelly PA, Davies JR, Malik IS, Kaprielian R, Mikhail G, Petraco R, Warisawa T, Al-Janabi F, Karamasis GV, Mohdnazri S, Gamma R, de Waard GA, Al-Lamee R, Keeble TR, Mayet J, Sen S, Francis DP, Davies JE.

JAMA Cardiol. 2019 Jun 1;4(6):569-574. doi: 10.1001/jamacardio.2019.1139.

PMID:
31042268
13.

Right ventricular pacing for hypertrophic obstructive cardiomyopathy: meta-analysis and meta-regression of clinical trials.

Arnold AD, Howard JP, Chiew K, Kerrigan WJ, de Vere F, Johns HT, Churlilov L, Ahmad Y, Keene D, Shun-Shin MJ, Cole GD, Kanagaratnam P, Sohaib SMA, Varnava A, Francis DP, Whinnett ZI.

Eur Heart J Qual Care Clin Outcomes. 2019 Oct 1;5(4):321-333. doi: 10.1093/ehjqcco/qcz006.

14.

Clinical Events After Deferral of LAD Revascularization Following Physiological Coronary Assessment.

Sen S, Ahmad Y, Dehbi HM, Howard JP, Iglesias JF, Al-Lamee R, Petraco R, Nijjer S, Bhindi R, Lehman S, Walters D, Sapontis J, Janssens L, Vrints CJ, Khashaba A, Laine M, Van Belle E, Krackhardt F, Bojara W, Going O, Härle T, Indolfi C, Niccoli G, Ribichini F, Tanaka N, Yokoi H, Takashima H, Kikuta Y, Erglis A, Vinhas H, Silva PC, Baptista SB, Alghamdi A, Hellig F, Koo BK, Nam CW, Shin ES, Doh JH, Brugaletta S, Alegria-Barrero E, Meuwissen M, Piek JJ, van Royen N, Sezer M, Di Mario C, Gerber RT, Malik IS, Sharp ASP, Talwar S, Tang K, Samady H, Altman J, Seto AH, Singh J, Jeremias A, Matsuo H, Kharbanda RK, Patel MR, Serruys P, Escaned J, Davies JE.

J Am Coll Cardiol. 2019 Feb 5;73(4):444-453. doi: 10.1016/j.jacc.2018.10.070.

15.

His Resynchronization Versus Biventricular Pacing in Patients With Heart Failure and Left Bundle Branch Block.

Arnold AD, Shun-Shin MJ, Keene D, Howard JP, Sohaib SMA, Wright IJ, Cole GD, Qureshi NA, Lefroy DC, Koa-Wing M, Linton NWF, Lim PB, Peters NS, Davies DW, Muthumala A, Tanner M, Ellenbogen KA, Kanagaratnam P, Francis DP, Whinnett ZI.

J Am Coll Cardiol. 2018 Dec 18;72(24):3112-3122. doi: 10.1016/j.jacc.2018.09.073.

16.

Coronary Hemodynamics in Patients With Severe Aortic Stenosis and Coronary Artery Disease Undergoing Transcatheter Aortic Valve Replacement: Implications for Clinical Indices of Coronary Stenosis Severity.

Ahmad Y, Götberg M, Cook C, Howard JP, Malik I, Mikhail G, Frame A, Petraco R, Rajkumar C, Demir O, Iglesias JF, Bhindi R, Koul S, Hadjiloizou N, Gerber R, Ramrakha P, Ruparelia N, Sutaria N, Kanaganayagam G, Ariff B, Fertleman M, Anderson J, Chukwuemeka A, Francis D, Mayet J, Serruys P, Davies J, Sen S.

JACC Cardiovasc Interv. 2018 Oct 22;11(20):2019-2031. doi: 10.1016/j.jcin.2018.07.019. Epub 2018 Aug 25.

17.

Impact of Percutaneous Revascularization on Exercise Hemodynamics in Patients With Stable Coronary Disease.

Cook CM, Ahmad Y, Howard JP, Shun-Shin MJ, Sethi A, Clesham GJ, Tang KH, Nijjer SS, Kelly PA, Davies JR, Malik IS, Kaprielian R, Mikhail G, Petraco R, Al-Janabi F, Karamasis GV, Mohdnazri S, Gamma R, Al-Lamee R, Keeble TR, Mayet J, Sen S, Francis DP, Davies JE.

J Am Coll Cardiol. 2018 Aug 28;72(9):970-983. doi: 10.1016/j.jacc.2018.06.033.

18.

Targeting the MTF2-MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to Chemotherapy.

Maganti HB, Jrade H, Cafariello C, Manias Rothberg JL, Porter CJ, Yockell-Lelièvre J, Battaion HL, Khan ST, Howard JP, Li Y, Grzybowski AT, Sabri E, Ruthenburg AJ, Dilworth FJ, Perkins TJ, Sabloff M, Ito CY, Stanford WL.

Cancer Discov. 2018 Nov;8(11):1376-1389. doi: 10.1158/2159-8290.CD-17-0841. Epub 2018 Aug 16.

19.

Rationale and design of the randomized multicentre His Optimized Pacing Evaluated for Heart Failure (HOPE-HF) trial.

Keene D, Arnold A, Shun-Shin MJ, Howard JP, Sohaib SA, Moore P, Tanner M, Quereshi N, Muthumala A, Chandresekeran B, Foley P, Leyva F, Adhya S, Falaschetti E, Tsang H, Vijayaraman P, Cleland JGF, Stegemann B, Francis DP, Whinnett ZI.

ESC Heart Fail. 2018 Oct;5(5):965-976. doi: 10.1002/ehf2.12315. Epub 2018 Jul 9. Review.

20.

Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Single-Vessel Coronary Artery Disease.

Al-Lamee R, Howard JP, Shun-Shin MJ, Thompson D, Dehbi HM, Sen S, Nijjer S, Petraco R, Davies J, Keeble T, Tang K, Malik IS, Cook C, Ahmad Y, Sharp ASP, Gerber R, Baker C, Kaprielian R, Talwar S, Assomull R, Cole G, Keenan NG, Kanaganayagam G, Sehmi J, Wensel R, Harrell FE, Mayet J, Thom SA, Davies JE, Francis DP.

Circulation. 2018 Oct 23;138(17):1780-1792. doi: 10.1161/CIRCULATIONAHA.118.033801.

21.

A Song of Pressure and Flow, or There and Back Again.

Howard JP, Murthy VL.

JACC Cardiovasc Interv. 2018 Apr 23;11(8):754-756. doi: 10.1016/j.jcin.2018.03.003. No abstract available.

22.

Patent foramen ovale closure vs. medical therapy for cryptogenic stroke: a meta-analysis of randomized controlled trials.

Ahmad Y, Howard JP, Arnold A, Shin MS, Cook C, Petraco R, Demir O, Williams L, Iglesias JF, Sutaria N, Malik I, Davies J, Mayet J, Francis D, Sen S.

Eur Heart J. 2018 May 7;39(18):1638-1649. doi: 10.1093/eurheartj/ehy121.

23.

Optimal antiplatelet strategy after transcatheter aortic valve implantation: a meta-analysis.

Ahmad Y, Demir O, Rajkumar C, Howard JP, Shun-Shin M, Cook C, Petraco R, Jabbour R, Arnold A, Frame A, Sutaria N, Ariff B, Kanaganayagam G, Francis D, Mayet J, Mikhail G, Malik I, Sen S.

Open Heart. 2018 Jan 26;5(1):e000748. doi: 10.1136/openhrt-2017-000748. eCollection 2018.

24.

Effects of disease severity distribution on the performance of quantitative diagnostic methods and proposal of a novel 'V-plot' methodology to display accuracy values.

Petraco R, Dehbi HM, Howard JP, Shun-Shin MJ, Sen S, Nijjer SS, Mayet J, Davies JE, Francis DP.

Open Heart. 2018 Jan 20;5(1):e000663. doi: 10.1136/openhrt-2017-000663. eCollection 2018.

25.

Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials.

Shun-Shin MJ, Zheng SL, Cole GD, Howard JP, Whinnett ZI, Francis DP.

Eur Heart J. 2017 Jun 7;38(22):1738-1746. doi: 10.1093/eurheartj/ehx028. Review.

26.

Dietary management of presumptive protein-losing enteropathy in Yorkshire terriers.

Rudinsky AJ, Howard JP, Bishop MA, Sherding RG, Parker VJ, Gilor C.

J Small Anim Pract. 2017 Feb;58(2):103-108. doi: 10.1111/jsap.12625.

PMID:
28160309
27.

A Simple and Robust Bedside Model for Mortality Risk in Pediatric Patients With Acute Respiratory Distress Syndrome.

Spicer AC, Calfee CS, Zinter MS, Khemani RG, Lo VP, Alkhouli MF, Orwoll BE, Graciano AL, Boriosi JP, Howard JP, Flori HR, Matthay MA, Sapru A.

Pediatr Crit Care Med. 2016 Oct;17(10):907-916.

28.

A propensity matched comparison of return to work and quality of life after stenting or coronary artery bypass surgery.

Maznyczka AM, Howard JP, Banning AS, Gershlick AH.

Open Heart. 2016 Jan 13;3(1):e000322. doi: 10.1136/openhrt-2015-000322. eCollection 2016.

29.

Quantifying the 3 Biases That Lead to Unintentional Overestimation of the Blood Pressure-Lowering Effect of Renal Denervation.

Howard JP, Shun-Shin MJ, Hartley A, Bhatt DL, Krum H, Francis DP.

Circ Cardiovasc Qual Outcomes. 2016 Jan;9(1):14-22. doi: 10.1161/CIRCOUTCOMES.115.002533. Epub 2016 Jan 12. Review.

PMID:
26758193
30.

Renal denervation for the management of resistant hypertension.

Patel HC, Hayward C, Vassiliou V, Patel K, Howard JP, Di Mario C.

Integr Blood Press Control. 2015 Dec 3;8:57-69. doi: 10.2147/IBPC.S65632. eCollection 2015. Review.

31.

Impact of number of prescribed medications on visit-to-visit variability of blood pressure: implications for design of future trials of renal denervation.

Howard JP, Patel H, Shun-Shin MJ, Mourad JJ, Blacher J, Mahfoud F, Zeller T, Weber M, Francis DP.

J Hypertens. 2015 Nov;33(11):2359-67. doi: 10.1097/HJH.0000000000000708.

PMID:
26372316
32.

The impact of socio-economic status on all-cause mortality after percutaneous coronary intervention: an observational cohort study of 13,770 patients.

Jones DA, Howard JP, Rathod KS, Gallagher SM, Knight CJ, Jain AK, Mathur A, Mohiddin SA, Mills PG, Timmis AD, Archbold RA, Wragg A.

EuroIntervention. 2015 Feb;10(10):e1-8. doi: 10.4244/EIJV10I10A196.

33.

Overcoming the three biases obscuring the science of renal denervation in humans: big-day bias, check-once-more bias and I-will-take-it-now bias.

Howard JP, Francis DP.

Trends Cardiovasc Med. 2015 Feb;25(2):116-8. doi: 10.1016/j.tcm.2014.10.011. Epub 2014 Oct 31. No abstract available.

PMID:
25467244
34.

Glycoprotein IIb/IIIa inhibitors use and outcome after percutaneous coronary intervention for non-ST elevation myocardial infarction.

Howard JP, Jones DA, Gallagher S, Rathod K, Antoniou S, Wright P, Knight C, Mathur A, Weerackody R, Wragg A.

Biomed Res Int. 2014;2014:643981. doi: 10.1155/2014/643981. Epub 2014 May 8.

35.

Recent advances in antithrombotic treatment for acute coronary syndromes.

Howard JP, Antoniou S, Jones DA, Wragg A.

Expert Rev Clin Pharmacol. 2014 Jul;7(4):507-21. doi: 10.1586/17512433.2014.923306. Epub 2014 May 31. Review.

PMID:
24882677
36.

2014 global geographic analysis of mortality from ischaemic heart disease by country, age and income: statistics from World Health Organisation and United Nations.

Nowbar AN, Howard JP, Finegold JA, Asaria P, Francis DP.

Int J Cardiol. 2014 Jun 15;174(2):293-8. doi: 10.1016/j.ijcard.2014.04.096. Epub 2014 Apr 13.

37.

Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis.

Nowbar AN, Mielewczik M, Karavassilis M, Dehbi HM, Shun-Shin MJ, Jones S, Howard JP, Cole GD, Francis DP; DAMASCENE writing group.

BMJ. 2014 Apr 28;348:g2688. doi: 10.1136/bmj.g2688. Review.

38.

Removing the hype from hypertension.

Shun-Shin MJ, Howard JP, Francis DP.

BMJ. 2014 Mar 6;348:g1937. doi: 10.1136/bmj.g1937. No abstract available. Erratum in: BMJ. 2014;348:g2088.

PMID:
24603957
39.

Unintentional overestimation of an expected antihypertensive effect in drug and device trials: mechanisms and solutions.

Howard JP, Cole GD, Sievert H, Bhatt DL, Papademetriou V, Kandzari DE, Davies JE, Francis DP.

Int J Cardiol. 2014 Mar 1;172(1):29-35. doi: 10.1016/j.ijcard.2013.12.183. Epub 2014 Jan 8. Review.

PMID:
24480181
40.

Size of blood pressure reduction from renal denervation: insights from meta-analysis of antihypertensive drug trials of 4,121 patients with focus on trial design: the CONVERGE report.

Howard JP, Nowbar AN, Francis DP.

Heart. 2013 Nov;99(21):1579-87. doi: 10.1136/heartjnl-2013-304238. Epub 2013 Sep 15.

PMID:
24038167
41.

Comparison of thermodilution measured extravascular lung water with chest radiographic assessment of pulmonary oedema in patients with acute lung injury.

Brown LM, Calfee CS, Howard JP, Craig TR, Matthay MA, McAuley DF.

Ann Intensive Care. 2013 Aug 11;3(1):25. doi: 10.1186/2110-5820-3-25.

42.

Federal drug permits.

Howard JP.

J Am Vet Med Assoc. 2013 Mar 1;242(5):602. doi: 10.2460/javma.242.5.602. No abstract available.

PMID:
23402403
43.

Large mediastinal nodular ganglioneuroblastoma in a child from Africa.

Guarino S, Astini C, Howard JP, Colombelli V.

Ann Ital Chir. 2012 Nov-Dec;83(6):543-6.

PMID:
23080230
44.

Safety and feasibility of hospital discharge 2 days following primary percutaneous intervention for ST-segment elevation myocardial infarction.

Jones DA, Rathod KS, Howard JP, Gallagher S, Antoniou S, De Palma R, Guttmann O, Cliffe S, Colley J, Butler J, Ferguson E, Mohiddin S, Kapur A, Knight CJ, Jain AK, Rothman MT, Mathur A, Timmis AD, Smith EJ, Wragg A.

Heart. 2012 Dec;98(23):1722-7. doi: 10.1136/heartjnl-2012-302414. Epub 2012 Oct 10.

PMID:
23053711
45.

Recurrent ascites due to constrictive pericarditis.

Howard JP, Jones D, Mills P, Marley R, Wragg A.

Frontline Gastroenterol. 2012 Oct;3(4):233-237. doi: 10.1136/flgastro-2012-100173. Epub 2012 Jul 19. No abstract available.

46.

Progress in modelling acute lung injury in a pre-clinical mouse model.

Matthay MA, Howard JP.

Eur Respir J. 2012 May;39(5):1062-3. doi: 10.1183/09031936.00204211. No abstract available.

47.

Concise review: Mesenchymal stem cells for acute lung injury: role of paracrine soluble factors.

Lee JW, Fang X, Krasnodembskaya A, Howard JP, Matthay MA.

Stem Cells. 2011 Jun;29(6):913-9. doi: 10.1002/stem.643. Review.

48.

Mesenchymal stem cells for acute lung injury: preclinical evidence.

Matthay MA, Goolaerts A, Howard JP, Lee JW.

Crit Care Med. 2010 Oct;38(10 Suppl):S569-73. doi: 10.1097/CCM.0b013e3181f1ff1d. Review.

49.

Pharmacologic advances in canine and feline reproduction.

Wiebe VJ, Howard JP.

Top Companion Anim Med. 2009 May;24(2):71-99. doi: 10.1053/j.tcam.2008.12.004. Review.

PMID:
19501345
50.

Protective mechanisms of activated protein C in severe inflammatory disorders.

Neyrinck AP, Liu KD, Howard JP, Matthay MA.

Br J Pharmacol. 2009 Oct;158(4):1034-47. doi: 10.1111/j.1476-5381.2009.00251.x. Epub 2009 May 14. Review.

Supplemental Content

Loading ...
Support Center